title: [Not Available].
abstract: CONS: Therapeutic de-escalation in breast cancer surgery is not recommanded for all patients. Concerning the axillary management, there are still some contraindications for practicing sentinel node, and avoiding axillary dissection is not safe for more than 3 positive sentinel nodes and in the absence of adjuvant treatment. Mastectomy can also be preferred by patients rather than conservative surgery, especially in case of genetic mutation, or for oncological reasons. Larger glandular resections, known as oncoplasties, should also be chosen in case of associated ductal carcinoma in situ and risky subgroups of local recurrence after neoadjuvant therapy. Finally, all patients will not benefit from ambulatory surgery.
authors: Service de chirurgie oncologique, ICM Val d'Aurelle, Parc Euromédecine, Montpellier, France. Electronic address: anne.mourregot@icm.unicancer.fr.
authors: Anne
authors: A
authors: Mourrégot
authors: Service de chirurgie oncologique, ICM Val d'Aurelle, Parc Euromédecine, Montpellier, France.
authors: Pierre-Emmanuel
authors: PE
authors: Colombo
authors: Service de chirurgie oncologique, ICM Val d'Aurelle, Parc Euromédecine, Montpellier, France.
authors: Philippe
authors: P
authors: Rouanet
mesh_terms: D001365:Axilla / Q000601:surgery; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D018270:Carcinoma, Ductal, Breast / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D000071036:Sentinel Lymph Node / Q000601:surgery*
keywords: Axiiiary dissection; Breast cancer surgery; Chirurgie cancer du sein; Curage axillaire; Hospitalisation; Mastectomie; Mastectomy; Oncopiasty; Oncoplastie; Traditionai hospitaiization; conventionnelle